Table of Content

1 RNA Drugs Market Overview
1.1 Product Overview and Scope of RNA Drugs
1.2 RNA Drugs Segment by Type
1.2.1 Global RNA Drugs Market Value Comparison by Type (2024-2034)
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 RNA Drugs Segment by Application
1.3.1 Global RNA Drugs Market Value by Application: (2024-2034)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA Drugs Market Size Estimates and Forecasts
1.4.1 Global RNA Drugs Revenue 2018-2034
1.4.2 Global RNA Drugs Sales 2018-2034
1.4.3 Global RNA Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 RNA Drugs Market Competition by Manufacturers
2.1 Global RNA Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA Drugs Average Price by Manufacturers (2018-2023)
2.4 Global RNA Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of RNA Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RNA Drugs, Product Type & Application
2.7 RNA Drugs Market Competitive Situation and Trends
2.7.1 RNA Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest RNA Drugs Players Market Share by Revenue
2.7.3 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA Drugs Retrospective Market Scenario by Region
3.1 Global RNA Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global RNA Drugs Global RNA Drugs Sales by Region: 2018-2034
3.2.1 Global RNA Drugs Sales by Region: 2018-2023
3.2.2 Global RNA Drugs Sales by Region: 2024-2034
3.3 Global RNA Drugs Global RNA Drugs Revenue by Region: 2018-2034
3.3.1 Global RNA Drugs Revenue by Region: 2018-2023
3.3.2 Global RNA Drugs Revenue by Region: 2024-2034
3.4 North America RNA Drugs Market Facts & Figures by Country
3.4.1 North America RNA Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America RNA Drugs Sales by Country (2018-2034)
3.4.3 North America RNA Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe RNA Drugs Market Facts & Figures by Country
3.5.1 Europe RNA Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe RNA Drugs Sales by Country (2018-2034)
3.5.3 Europe RNA Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific RNA Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific RNA Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific RNA Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America RNA Drugs Market Facts & Figures by Country
3.7.1 Latin America RNA Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America RNA Drugs Sales by Country (2018-2034)
3.7.3 Latin America RNA Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa RNA Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa RNA Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa RNA Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global RNA Drugs Sales by Type (2018-2034)
4.1.1 Global RNA Drugs Sales by Type (2018-2023)
4.1.2 Global RNA Drugs Sales by Type (2024-2034)
4.1.3 Global RNA Drugs Sales Market Share by Type (2018-2034)
4.2 Global RNA Drugs Revenue by Type (2018-2034)
4.2.1 Global RNA Drugs Revenue by Type (2018-2023)
4.2.2 Global RNA Drugs Revenue by Type (2024-2034)
4.2.3 Global RNA Drugs Revenue Market Share by Type (2018-2034)
4.3 Global RNA Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global RNA Drugs Sales by Application (2018-2034)
5.1.1 Global RNA Drugs Sales by Application (2018-2023)
5.1.2 Global RNA Drugs Sales by Application (2024-2034)
5.1.3 Global RNA Drugs Sales Market Share by Application (2018-2034)
5.2 Global RNA Drugs Revenue by Application (2018-2034)
5.2.1 Global RNA Drugs Revenue by Application (2018-2023)
5.2.2 Global RNA Drugs Revenue by Application (2024-2034)
5.2.3 Global RNA Drugs Revenue Market Share by Application (2018-2034)
5.3 Global RNA Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA Drugs Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA Drugs Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA Drugs Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA Drugs Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA Drugs Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA Drugs Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA Drugs Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA Drugs Description and Business Overview
6.11.3 RXi RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA Drugs Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA Drugs Description and Business Overview
6.12.3 Senesco RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA Drugs Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA Drugs Description and Business Overview
6.13.3 Silence Therapeutics RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA Drugs Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA Drugs Description and Business Overview
6.14.3 Silenseed RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA Drugs Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA Drugs Description and Business Overview
6.15.3 Tekmira RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA Drugs Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA Drugs Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA Drugs Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Drugs Industry Chain Analysis
7.2 RNA Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Drugs Production Mode & Process
7.4 RNA Drugs Sales and Marketing
7.4.1 RNA Drugs Sales Channels
7.4.2 RNA Drugs Distributors
7.5 RNA Drugs Customers
8 RNA Drugs Market Dynamics
8.1 RNA Drugs Industry Trends
8.2 RNA Drugs Market Drivers
8.3 RNA Drugs Market Challenges
8.4 RNA Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global RNA Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global RNA Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global RNA Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global RNA Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global RNA Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global RNA Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global RNA Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market RNA Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of RNA Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of RNA Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of RNA Drugs, Product Type & Application
Table 12. Global Key Manufacturers of RNA Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global RNA Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global RNA Drugs Sales Market Share by Region (2018-2023)
Table 19. Global RNA Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global RNA Drugs Sales Market Share by Region (2024-2034)
Table 21. Global RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global RNA Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global RNA Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global RNA Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific RNA Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific RNA Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific RNA Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific RNA Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific RNA Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa RNA Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa RNA Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa RNA Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa RNA Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa RNA Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global RNA Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global RNA Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global RNA Drugs Sales Market Share by Type (2018-2023)
Table 53. Global RNA Drugs Sales Market Share by Type (2024-2034)
Table 54. Global RNA Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global RNA Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global RNA Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global RNA Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global RNA Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global RNA Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global RNA Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global RNA Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global RNA Drugs Sales Market Share by Application (2018-2023)
Table 63. Global RNA Drugs Sales Market Share by Application (2024-2034)
Table 64. Global RNA Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global RNA Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global RNA Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global RNA Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global RNA Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global RNA Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer RNA Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Roche RNA Drugs Product
Table 79. Roche Recent Developments/Updates
Table 80. Sanofi-Aventis Corporation Information
Table 81. Sanofi-Aventis Description and Business Overview
Table 82. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi-Aventis RNA Drugs Product
Table 84. Sanofi-Aventis Recent Developments/Updates
Table 85. Abbott Laboratories Corporation Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Laboratories RNA Drugs Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Arrowhead Pharmaceuticals Corporation Information
Table 91. Arrowhead Pharmaceuticals Description and Business Overview
Table 92. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Arrowhead Pharmaceuticals RNA Drugs Product
Table 94. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 95. Benitec Biopharma Corporation Information
Table 96. Benitec Biopharma Description and Business Overview
Table 97. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Benitec Biopharma RNA Drugs Product
Table 99. Benitec Biopharma Recent Developments/Updates
Table 100. Calimmune Inc Corporation Information
Table 101. Calimmune Inc Description and Business Overview
Table 102. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Calimmune Inc RNA Drugs Product
Table 104. Calimmune Inc Recent Developments/Updates
Table 105. Dicerna Corporation Information
Table 106. Dicerna Description and Business Overview
Table 107. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Dicerna RNA Drugs Product
Table 109. Dicerna Recent Developments/Updates
Table 110. Gradalis Corporation Information
Table 111. Gradalis Description and Business Overview
Table 112. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Gradalis RNA Drugs Product
Table 114. Gradalis Recent Developments/Updates
Table 115. Quark Corporation Information
Table 116. Quark Description and Business Overview
Table 117. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Quark RNA Drugs Product
Table 119. Quark Recent Developments/Updates
Table 120. RXi Corporation Information
Table 121. RXi Description and Business Overview
Table 122. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. RXi RNA Drugs Product
Table 124. RXi Recent Developments/Updates
Table 125. Senesco Corporation Information
Table 126. Senesco Description and Business Overview
Table 127. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Senesco RNA Drugs Product
Table 129. Senesco Recent Developments/Updates
Table 130. Silence Therapeutics Corporation Information
Table 131. Silence Therapeutics Description and Business Overview
Table 132. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Silence Therapeutics RNA Drugs Product
Table 134. Silence Therapeutics Recent Developments/Updates
Table 135. Silenseed Corporation Information
Table 136. Silenseed Description and Business Overview
Table 137. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Silenseed RNA Drugs Product
Table 139. Silenseed Recent Developments/Updates
Table 140. Tekmira Corporation Information
Table 141. Tekmira Description and Business Overview
Table 142. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Tekmira RNA Drugs Product
Table 144. Tekmira Recent Developments/Updates
Table 145. Alnylam Pharmaceuticals Corporation Information
Table 146. Alnylam Pharmaceuticals Description and Business Overview
Table 147. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Alnylam Pharmaceuticals RNA Drugs Product
Table 149. Alnylam Pharmaceuticals Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. RNA Drugs Distributors List
Table 153. RNA Drugs Customers List
Table 154. RNA Drugs Market Trends
Table 155. RNA Drugs Market Drivers
Table 156. RNA Drugs Market Challenges
Table 157. RNA Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA Drugs
Figure 2. Global RNA Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global RNA Drugs Market Share by Type in 2024 & 2034
Figure 4. siRNA Product Picture
Figure 5. ASO Product Picture
Figure 6. miRNA Product Picture
Figure 7. Nucleic Acid Aptamers Product Picture
Figure 8. Global RNA Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global RNA Drugs Market Share by Application in 2024 & 2034
Figure 10. Cancer
Figure 11. Diabetes
Figure 12. Tuberculosis
Figure 13. Cardiovascular Diseases
Figure 14. Others
Figure 15. Global RNA Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global RNA Drugs Market Size (2018-2034) & (US$ Million)
Figure 17. Global RNA Drugs Sales (2018-2034) & (K Units)
Figure 18. Global RNA Drugs Average Price (USD/Unit) & (2018-2034)
Figure 19. RNA Drugs Report Years Considered
Figure 20. RNA Drugs Sales Share by Manufacturers in 2024
Figure 21. Global RNA Drugs Revenue Share by Manufacturers in 2024
Figure 22. The Global 5 and 10 Largest RNA Drugs Players: Market Share by Revenue in 2024
Figure 23. RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 24. Global RNA Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 25. North America RNA Drugs Sales Market Share by Country (2018-2034)
Figure 26. North America RNA Drugs Revenue Market Share by Country (2018-2034)
Figure 27. U.S. RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Canada RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Europe RNA Drugs Sales Market Share by Country (2018-2034)
Figure 30. Europe RNA Drugs Revenue Market Share by Country (2018-2034)
Figure 31. Germany RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. France RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. U.K. RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Italy RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Russia RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Asia Pacific RNA Drugs Sales Market Share by Region (2018-2034)
Figure 37. Asia Pacific RNA Drugs Revenue Market Share by Region (2018-2034)
Figure 38. China RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Japan RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. South Korea RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. India RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Australia RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Taiwan RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Indonesia RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Thailand RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Malaysia RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Philippines RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America RNA Drugs Sales Market Share by Country (2018-2034)
Figure 49. Latin America RNA Drugs Revenue Market Share by Country (2018-2034)
Figure 50. Mexico RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa RNA Drugs Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa RNA Drugs Revenue Market Share by Country (2018-2034)
Figure 55. Turkey RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. U.A.E RNA Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of RNA Drugs by Type (2018-2034)
Figure 59. Global Revenue Market Share of RNA Drugs by Type (2018-2034)
Figure 60. Global RNA Drugs Price (USD/Unit) by Type (2018-2034)
Figure 61. Global Sales Market Share of RNA Drugs by Application (2018-2034)
Figure 62. Global Revenue Market Share of RNA Drugs by Application (2018-2034)
Figure 63. Global RNA Drugs Price (USD/Unit) by Application (2018-2034)
Figure 64. RNA Drugs Value Chain
Figure 65. RNA Drugs Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed